Radar Therapeutics

About Radar Therapeutics

Radar Therapeutics is pioneering precision-expressed mRNA-based therapeutics, aiming to conquer intractable diseases with smart, targeted therapies. Their RADAR platform enables precise control of mRNA messages in specific cells to avoid toxic side-effects, leveraging single-cell transcriptomic data and RNA-editing enzyme advances for programmable RNA therapies.

Products & Services

RADAR Platform:A precision therapeutics platform for targeted, timely, and controlled reading of mRNA messages in specific cells, ensuring safety by avoiding non-target cells, scalability through in vivo reprogramming, and universality by reading RNA profiles.

Smart mRNA Therapies:Programmable genetic medicines that read cell profiles to act only in the right cells at the right time, enabling accurate reprogramming of desired cells within the body.

Specialties

Precision mRNA-based Therapeutics Synthetic Biology RNA-editing Enzymes Single-cell Transcriptomics Programmable RNA Sensors

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 13400000 MR: - FA: 13.4 million FAN: 13400000	D: 2024-05-23 FD: 2024-05-23	6 investors

Seed Latest

2024-05-23

$13.4M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Sophia Lugo

CEO

LinkedIn (Pro only)

E

Eerik Kaseniit

CSO & President

LinkedIn (Pro only)

A

Andrew Fraley

Chief of Innovation & Strategy

LinkedIn (Pro only)

B

Barbara Mertins

VP of Scientific Operations

M

Makenna Morck

Chief of staff

T

Tony Lau

Principal Scientist

View 18 more team members with Pro

Unlock Full Team Directory

Recent News